Company intelligence / Profile preview

Hong Kong Universal Biologicals Company Limited

Ownership: Private
Development stage: Other

Overview

HKUBio has developed a proprietary live attenuated influenza viral vector vaccine platform enabling intranasal vaccines against major respiratory viruses. The technology underpinned collaborative efforts that led to approval of the world’s first intranasal COVID‑19 vaccine for emergency use in mainland China. The company is advancing a pipeline including seasonal flu, avian flu H5N1, RSV, bivalent flu-COVID vaccines, and gene delivery systems targeting lung cancer. Their approach aims to provide broad-spectrum mucosal immunity superior to traditional injectable vaccines.

Therapeutic areas: Infectious Diseases
Modalities: Live attenuated viral vectorsGene delivery systems
Industry: Biotech

Drug pipeline

6 assets

HKUB-004

Preclinical

5 more assets in the full pipeline.

Partnerships

Xiamen UniversityBeijing Wantai BiopharmCentre for Virology, Vaccinology and Therapeutics (CVVT)

Beyond the preview

Go deeper on Hong Kong Universal Biologicals Company Limited.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hong Kong Universal Biologicals Company Limited.